Coomeva Entidad Promotora de Salud S.A.

BVC:COOMEVAEPS Stock Report

Market Cap: Col$125.4b

Coomeva Entidad Promotora de Salud Past Earnings Performance

Past criteria checks 0/6

Coomeva Entidad Promotora de Salud's earnings have been declining at an average annual rate of -46.8%, while the Healthcare industry saw earnings growing at 11.6% annually. Revenues have been declining at an average rate of 8.4% per year.

Key information

-46.8%

Earnings growth rate

-36.8%

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth rate-8.4%
Return on equityn/a
Net Margin-7.8%
Last Earnings Update30 Sep 2021

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Coomeva Entidad Promotora de Salud makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BVC:COOMEVAEPS Revenue, expenses and earnings (COP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 212,295,677-178,371112,3290
30 Jun 212,353,587-82,635110,8930
31 Mar 212,433,785-26,698107,3550
31 Dec 202,450,410-32,263113,5700
30 Sep 202,475,68610,998133,9970
30 Jun 202,574,119-35,215140,3420
31 Mar 202,809,829-61,687151,7600
31 Dec 192,756,457-58,916153,9830
30 Sep 192,907,612-46,471142,4520
30 Jun 192,975,42913,588147,5060
31 Mar 192,896,235-6,853154,0290
31 Dec 182,976,8778,472157,5920
30 Sep 183,106,5078,297169,2210
30 Jun 183,169,624-24,273171,4500
31 Mar 183,212,034-7,835172,2300
31 Dec 173,285,491-19,461174,2970
30 Sep 173,288,48823,276166,9640
30 Jun 173,359,315-20,102165,8980
31 Mar 173,406,493-8,562163,4120
31 Dec 163,448,108-12,589161,7960
30 Sep 163,470,513-19,35892,7860
30 Jun 163,378,964-29,400114,4100
31 Mar 163,386,5721,590143,6020
31 Dec 153,245,468-51,449168,7330

Quality Earnings: COOMEVAEPS is currently unprofitable.

Growing Profit Margin: COOMEVAEPS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: COOMEVAEPS is unprofitable, and losses have increased over the past 5 years at a rate of 46.8% per year.

Accelerating Growth: Unable to compare COOMEVAEPS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: COOMEVAEPS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (2.2%).


Return on Equity

High ROE: COOMEVAEPS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.